These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7871373)

  • 1. The novel anti-ulcer agent ecabet sodium (TA-2711) eradicates Helicobacter pylori colonizing on the gastric mucosa of Japanese monkeys.
    Fukuda Y; Mizuta T; Yamamoto I; Tamura K; Shimoyama T
    Scand J Gastroenterol; 1994 Nov; 29(11):1055-6. PubMed ID: 7871373
    [No Abstract]   [Full Text] [Related]  

  • 2. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
    Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Yachi A; Yokota K; Hirai Y; Oguma K; Fujii N
    J Gastroenterol; 1997 Oct; 32(5):593-7. PubMed ID: 9349983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8.
    Shimoyama T; Fukuda S; Liu Q; Nakaji S; Munakata A; Sugawara K
    J Gastroenterol; 2001 Mar; 36(3):153-7. PubMed ID: 11291877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.
    Koizumi W; Tanabe S; Imaizumi H; Kida M; Ohida M; Koshida Y; Mitomi H; Hosaka Y; Nagaba S; Sasaki T; Higuchi K; Saigenji K
    Hepatogastroenterology; 2003; 50(50):577-81. PubMed ID: 12749277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of a new anti-ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection.
    Ohkusa T; Takashimizu I; Fujiki K; Araki A; Ariake K; Shimoi K; Honda K; Enomoto Y; Sakurazawa T; Horiuchi T; Suzuki S; Ishii K; Ishikura T
    Aliment Pharmacol Ther; 1998 May; 12(5):457-61. PubMed ID: 9663726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
    Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
    Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
    Hayashi S; Sugiyama T; Yokota K; Isogai H; Isogai E; Shimomura H; Oguma K; Asaka M; Hirai Y
    Microbiol Immunol; 2000; 44(7):557-62. PubMed ID: 10981828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis.
    Wang Y; Wang B; Lv ZF; Yang Y; Wang F; Wang H; Chen S; Xie Y; Zhou X
    Helicobacter; 2014 Oct; 19(5):372-81. PubMed ID: 24826809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
    Koizumi W; Tanabe S; Nakatani K; Ishido K; Nishimura K; Azuma M; Ae T; Sasaki T; Higuchi K; Katada C; Nakayama N; Saigenji K
    J Clin Pharm Ther; 2010 Jun; 35(3):303-7. PubMed ID: 20831531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
    Kagaya H; Kato M; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():455-9. PubMed ID: 11979827
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ecabet sodium].
    Takahashi S; Tanaka A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():711-6. PubMed ID: 11979876
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
    Kim J; Kim K; Lee JS; Kim SY; Kim KO; Kim YJ; Kwon KA; Park DK; Chung JW
    Korean J Gastroenterol; 2018 Apr; 71(4):204-212. PubMed ID: 29684969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of anti-ulcer agents and the extent of gastric mucosa contamination with Helicobacter pylori].
    Orziev ZM
    Klin Med (Mosk); 2001; 79(2):57-8. PubMed ID: 11419090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori.
    Ito Y; Shibata K; Hongo A; Kinoshita M
    Eur J Pharmacol; 1998 Mar; 345(2):193-8. PubMed ID: 9600637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter heilmannii associated erosive gastritis.
    Yamamoto T; Matsumoto J; Shiota K; Kitajima S; Goto M; Imaizumi M; Arima T
    Intern Med; 1999 Mar; 38(3):240-3. PubMed ID: 10337933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori.
    Shibata K; Kasuga O; Yasoshima A; Matsushita T; Kawakami Y
    Jpn J Antibiot; 1997 Jun; 50(6):525-31. PubMed ID: 9258741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat.
    Kinoshita M; Endo M; Yasoshima A; Saito N; Yamasaki K; Chishima S; Narita H
    Aliment Pharmacol Ther; 1999 May; 13(5):687-94. PubMed ID: 10233194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines.
    Miyake K; Tsukui T; Shinji Y; Shinoki K; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Gudis K; Iwakiri K; Yamada N; Sakamoto C
    Helicobacter; 2004 Apr; 9(2):130-7. PubMed ID: 15068414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The impact of the degree of Helicobacter pylori semination of the mucous coat of stomach in patients with duodenal ulcer on the infectious organism's eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2004; (3):19-23, 102. PubMed ID: 15560395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.